• 
• 
• 

Our growing elderly population… a better vision for the future?

By the mid 2030s the number of people aged 85 and over is projected to double to reach 3.2 million, while more than 10 million people alive today will live to be 100. This demographic shift has significantly increased the prevalence of age-related diseases of the eye, especially those requiring treatment to the back of the eye such as age-related macular degeneration, diabetic retinopathy, and glaucoma. However, a number of physiological barriers in the eye and inefficient drug delivery systems prevent the effective treatment of these conditions… often resulting in blindness.

Dr Eileen McBride

Dr Eileen McBride is a post-doctoral research fellow in drug delivery at the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde in Glasgow. In her presentation at the Institute of Nanotechnology’s forthcoming conference Advanced Technologies for an Ageing Population, Dr McBride will explain how these serious eye diseases affect the elderly population and what the challenges associated with their treatment are. She will review the current approaches to delivering drugs and the pitfalls associated with them, and will explore the application of advanced technologies, including MEMS delivery devices, asking the question “Can micro become nano in this space and is it appropriate?”

Full Details and Registration

Leave a Comment